SALUS, Ljubljana, d. d. agreed to acquire 58% stake in Sanolabor, d.d., Ljubljana for €10.4 million.
July 19, 2018
Share
SALUS, Ljubljana, d. d. (LJSE:SALR) agreed to acquire 58% stake in Sanolabor, d.d., Ljubljana for €10.4 million on May 23, 2018. SALUS plans to finance the potential takeover through a combination of own sources and debt capital. On July 20, 2018, the shareholders of SALUS approved the deal empowering the management to sign a contract on the acquisition.
Salus Ljubljana dd is a Slovenia-based company engaged in the wholesale and distribution of medical products. The Companyâs portfolio includes pharmaceuticals, medical devices, medical supplies, food supplements, cosmetic products and other health products. The Company's core clients are pharmacies, hospitals and health centers from both Slovenia and abroad. Moreover, Salus Ljubljana dd offers the products to its business partners through the Internet store. The Company also provides additional services related to the registration of medicines and the distribution and storage of pharmaceuticals and other medical products.
SALUS, LJUBLJANA, D. D. 
